Press Releases

Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study

Aethlon Medical Announces Withdrawal of S-1 Registration Statement

Aethlon Medical Discloses Presentation of Preliminary CTE Related Study Results

Aethlon Medical Announces Cancer Clinical Trial Agreement

Aethlon Medical Announces Effectiveness of Reverse Stock Split

Aethlon Medical Announces Ebola Humanitarian Use Device Submission to the FDA

Aethlon Medical Announces Reverse Stock Split and Nasdaq Listing Submission

Aethlon Medical Discloses Head and Neck Cancer Collaboration

Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference

Aethlon Medical to Present at the 27th Annual ROTH Conference